NattoPharma has filed a new MenaQ7 patent which combines the benefits of MenaQ7 (vitamin K2) with other food supplements such as fish-oil. "Research we performed in close collaboration with VitaK at the Maastricht University has shown that a combination of MenaQ7 with products containing Omega-3 has additional benefit compared to the sum of both individual ingredients.
"Adding the two compounds makes 1 + 1 = 3" says Morten Sundstø, CEO of NattoPharma. NattoPharma had already a patent on the combination of vitamin K2 and fish-oils in their portfolio and with the new patent it makes NattoPharma the only company in the world having a protection on the combination of vitamin K2 with fish-oil. "Our new patents will strengthen our unique position, especially in the fish-oil market. This makes NattoPharma an interesting and attractive partner for companies producing or selling fish-oil. Both MenaQ7 and fish-oil has been proven to prevent cardiovascular diseases at a different level, which makes the combination of them truly interesting" says Sundstø.
For further information, please contact:
Dr. Leon J Schurgers
Vice President R&D
NattoPharma ASA
+31 43 388 1680
Morten Sundstø
President & CEO
NattoPharma ASA
+47 950 61860

About Us

NattoPharma, the world leader in Vitamin K2 Research and Development, has invested millions of dollars in in-vitro, in-vivo, and clinical studies to document the effects of MenaQ7® Vitamin K2 as MK-7. This commitment has created the only patented and clinically validated K2 on the market. After establishing the first commercial Vitamin K2 with its flagship brand, MenaQ7®, NattoPharma has consistently answered and met market needs through the development of new production technologies:• In 2012, the company introduced MenaQ7® Crystals, which represented an important breakthrough in the new generation of Vitamin K2 products, producing the purest natural MK-7 available.• In 2014, NattoPharma introduced the only all-trans nature-identical synthesized Vitamin K2, MenaQ7® PURE. Not only did the company succeed in changing the market with MenaQ7® PURE – offering a high-quality, competitively priced ingredient – but its efforts were rewarded with the NutrAward for Best Functional Ingredient at Natural Products West/engredea 2015. Vitamin K2 is essential for the body to utilize calcium to build healthy, strong bones and to inhibit calcium deposits in the arteries. Published clinical studies have demonstrated the high bioavailability and proof of efficacy for Nattopharma’s all-trans MK-7 products in healthy and diseased populations, for bone and cardiovascular health. NattoPharma continues to build its competitive advantage through focuson IPR and has patents both granted and pending related to relevant healthbenefits and market segments, creating extra value for its customers. And NattoPharma staff consists of professionals people with longstanding experience in medical and biochemical research as well as pharmaceutical and food supplement development. By understanding and controlling the chemistry, NattoPharma provides the market all-trans MK-7 products, while our sales and marketing team has extensive knowledge of international market demands with which it supports our partners.


Documents & Links